CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 600 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02645968
NCT02645968N/ACompleted
CompareCT.gov

Registry for Exploring Clinical and Epidemiological Characteristics of Interstitial Lung Diseases - EXCITING

Heidelberg University·observational·Posted Jan 5, 2016·Updated Dec 7, 2020

In Brief

An observational study for Interstitial Lung Disease (ILD). Completed, enrolled 600 participants across 22 sites.

Detailed Summary

The purpose of this study is to collect valid data from all forms of health care on the incidence, prevalence, the regional distribution, characteristics, management and outcomes of different ILDs under clinical practice conditions.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsInterstitial Lung Disease (ILD)
CountriesGermany
CollaboratorsUniversity of Giessen, German Center for Lung Research, Helmholtz Zentrum München, Institut für Lungenforschung e.V., German Respiratory Society, WATL e.V., Bundesverband der Pneumologen, Lungenfibrose e.V., Sacura GmbH, Syneed Medidata GmbH

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJan 5, 2016
Enrollment StartMay 1, 2014
Primary CompletionApr 1, 2020
Study CompletionMay 1, 2020
TodayJul 2, 2026
Enrollment to primary: 5.9 yearsPosted 10.5 years ago